Median survival duration in months | PtsNo. | Prognostic factor | |||
p | OS | p | PFS | ||
| 39 - | 14 - | 58 | All patients | ||
|
NS |
34 40 |
NS |
13 16 |
38 20 | Sex Male female |
|
NS |
50 36 |
NS |
29 11 |
18 40 | WHO PS 0.1 >2 |
|
NS |
39 40 |
NS |
12 15 |
26 32 | Bulky disease Yes No |
|
NS |
49 30 |
0.03 |
20 11 |
27 31 | Stage before LTBI II/III IV |
|
NS |
53 24 |
0.05 |
23 9 |
13 45 | No. of chemotherapy 1 - 2 regimen >3 regimen |
|
NS |
33 44 |
NS |
13 18 |
22 36 | B symptoms Yes No |
|
NS |
21 44 |
NS |
10 19 |
17 41 | Extra nodal disesae Yes No |
|
NS |
32 43 |
NS |
13 17 |
23 35 | IFRT Yes No |
|
0.05 |
49 28 |
0.01 |
24 7 |
40 12 | Response to LTBI CR/PR SD |